Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Amortizatization of Intangibles (2023 - 2025)

Kura Oncology (KURA) has disclosed Amortizatization of Intangibles for 3 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 52.1% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.5 million, a 35.41% decrease, with the full-year FY2025 number at $8.5 million, down 35.41% from a year prior.
  • Amortizatization of Intangibles was $1.4 million for Q4 2025 at Kura Oncology, down from $1.9 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $3.5 million in Q2 2024 to a low of $1.4 million in Q4 2025.
  • A 3-year average of $2.6 million and a median of $2.7 million in 2023 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: surged 93.84% in 2024, then plummeted 52.1% in 2025.
  • Kura Oncology's Amortizatization of Intangibles stood at $2.7 million in 2023, then increased by 5.56% to $2.9 million in 2024, then tumbled by 52.1% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Amortizatization of Intangibles are $1.4 million (Q4 2025), $1.9 million (Q3 2025), and $2.5 million (Q2 2025).